Contact Us
Products & Technologies
Technology Overview
PhysioLab
PhysioLab Platforms
Virtual Patients and Populations
Realab
Toxicogenomics
DrugMatrix
Drug Signatures
ToxFX
Toxicogenomics Solutions
DigitalSelf
Solutions
Overview
Our Engagements
Discovery
Pre-Clinical
Clinical & Marketing
Toxicology & Safety
Financial Applications
Compound Rescue
Our Partners
Case Studies
Therapeutic Expertise
Overview
Video Overviews
Cardiovascular
Metabolism
Type I Diabetes
Respiratory
Rheumatoid Arthritis
Hypertension
Hematopoiesis/Anemia
Skin Sensitization
Cosmeceuticals
Consumer Products
Toxicogenomics
In Development
Company
About Us
Management
Board of Directors
Scientific Advisors
Investor Relations
Careers
Contact Us
News & Publications
News Releases
Media Coverage
Entelos Publications
Events
Extract more insights and make better decisions.
Combining your data with the power of simulation, we create computer models of human biology to help you gain more insight and make smarter decisions. We reduce your risk by identifying successful treatments and recommending specific protocols, before you invest years in research and clinical development.
»
Run a virtual clinical trial first!
Optimize dosing and endpoints before running the clinical trial.
»
Cardiovascular evaluation.
Entelos is helping the FDA and pharma better understand cardiovascular efficacy and safety effects of drugs.
»
Visit with Entelos.
Entelos speaking and exhibiting engagements in 2010.
»
Learn about the Entelos PhysioLab
®
Platforms.
Entelos scientists present brief video overviews of how Entelos technology and expertise are applied to various therapeutic areas.
Learn how we have helped our pharmaceutical and consumer products partners make better decisions throughout their R&D pipelines:
identify patient responders and biomarkers
»
optimize clinical trials
»
evaluate in-licensing opportunities
»
identify drug toxicities
»
evaluate and validate targets
»
predict human response
»
Contact Us